Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Biotricity (BTCY) Stock Price & Analysis

BTCY Stock Chart & Stats

$0.06-$0.00(-5.17%)
At close: 4:00 PM EDT
$0.05$0.075$0.1$0.1253 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$0.06 - $0.06
52-Week Range
$0.04 - $0.59
Previous Close
$0.06
Volume
92
Average Volume (3M)
75.40K
Market Cap
$1.20M
Enterprise Value
$33.48M
Total Cash (Recent Filing)
$466.50K
Total Debt (Recent Filing)
$26.93M
Price to Earnings (P/E)
―
Beta
0.01
Next Earnings
Nov 13, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Strong and consistent revenue expansion indicates improving commercial traction for Biotricity’s cardiac monitoring offerings. Continued top-line growth can broaden the installed customer base, support operating leverage, and provide a foundation for improved earnings as the business scales over the next several quarters.

Gross Margin And Operating Profit

Very high gross margins and a positive operating result show that the core offering can generate attractive economics before below-the-line costs. If maintained, this combination gives management room to fund commercialization, absorb fixed costs, and move closer to sustainable bottom-line profitability.

Integrated Cardiac Monitoring Platform

Combining wearable cardiac devices with software and clinical support tools creates an integrated proposition for monitoring and managing cardiac conditions. This platform approach can deepen clinician use, improve workflow continuity, and support broader adoption than a standalone hardware product.

Bears Say

Negative Equity And Leverage

Negative equity and meaningful debt indicate a structurally strained capital position, reducing financial flexibility and increasing dependence on external funding. This can constrain investment in growth, raise refinancing exposure, and create dilution risk if additional capital is needed to support operations.

Persistent Net Losses

The gap between positive operating profit and continuing net losses shows that the turnaround has not yet reached the bottom line. Ongoing costs or non-operating burdens may continue consuming the benefits of growth, delaying internally funded expansion and weakening financial resilience.

Inconsistent Cash Generation

Cash generation has not yet demonstrated a dependable trend: recent TTM improvement follows negative annual cash flow and deeper consumption in earlier periods. Because current operating cash flow remains small relative to debt, the company has limited capacity to delever without external funding.

Biotricity News

BTCY FAQ

What was Biotricity’s price range in the past 12 months?
Biotricity lowest stock price was $0.04 and its highest was $0.59 in the past 12 months.
What is Biotricity’s market cap?
Biotricity’s market cap is $1.20M.
When is Biotricity’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Biotricity’s earnings last quarter?
Biotricity released its earnings results on Aug 17, 2026. The company reported -$0.046 earnings per share for the quarter.
Is Biotricity overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Biotricity pay dividends?
Biotricity does not currently pay dividends.
What is Biotricity’s EPS estimate?
Biotricity’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biotricity have?
Biotricity has 21,631,493 shares outstanding.
What happened to Biotricity’s price movement after its last earnings report?
Biotricity reported an EPS of -$0.046 in its last earnings report. Following the earnings report the stock price went down -1.724%.
Which hedge fund is a major shareholder of Biotricity?
Currently, no hedge funds are holding shares in BTCY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology